Recently, it was observed a fatal heterozygous mutation in CTLA‐4, predicted to decrease protein stability resulting in haploinsufficiency and decreased CTLA‐4 expression in a patient reporting autoimmunity (Evan’s syndrome), lymphoproliferation and severe infections (Moraes-Fontes et al., 2017). This evidence concerns the gene CTLA4 and Evans syndrome.